Future Oncology Study: Augmented Intelligence to Predict 30-day Mortality in Patients with Cancer

With more than 1.6 million Americans diagnosed with cancer each year, oncology providers are turning to AI-powered prescriptive insights to deliver better care.

In a recent study published by Future Oncology, Cardinal Health Speciality Solutions, Jvion and Northwest Medical Specialties report that Jvion’s clinical AI accurately predicts short-term mortality risk among patients with cancer and guides the appropriate use of interventions and palliative care services.

  • By 2023, 2.3 million people will be newly diagnosed with cancer in the U.S.1
  • By 2030, the number of cancer survivors is projected to increase by 31.4%, to 22.2 million2

1 IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press.
2 National Cancer Institute Division of Cancer Control & Population Sciences. 2020.

Get in Touch

  • 470-427-2900, 3965 Johns Creek Court, Suite 100, Suwanee, GA 30024
  • This field is for validation purposes and should be left unchanged.

Request a demo

  • Download the latest SmartFocus paper “The COVID Aftermath: Why behavioral health is the next crisis health plans should be prepared to manage” brought to you by Jvion and SmartBrief to understand why the current state of analytics leave members and health plans exposed to a behavioral health crisis.

  • We respect your privacy.
  • This field is for validation purposes and should be left unchanged.